Annual Revenue Comparison: Lantheus Holdings, Inc. vs Telix Pharmaceuticals Limited

Lantheus vs Telix: A Decade of Revenue Growth

__timestampLantheus Holdings, Inc.Telix Pharmaceuticals Limited
Wednesday, January 1, 201430160000028336824
Thursday, January 1, 201529346100032319194
Friday, January 1, 201630185300029404631
Sunday, January 1, 201733137800031769230
Monday, January 1, 201834337400020439380
Tuesday, January 1, 201934733700024186536
Wednesday, January 1, 20203394100004680000
Friday, January 1, 20214252080004898000
Saturday, January 1, 2022935061000155984000
Sunday, January 1, 20231296429000496659000
Loading chart...

Cracking the code

A Tale of Two Companies: Lantheus Holdings, Inc. vs Telix Pharmaceuticals Limited

In the ever-evolving landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Lantheus Holdings, Inc. and Telix Pharmaceuticals Limited have showcased contrasting trajectories. Lantheus Holdings, Inc. has seen a remarkable revenue surge, growing by over 330% from 2014 to 2023. This growth is highlighted by a significant leap in 2022, where revenue nearly doubled compared to the previous year.

Conversely, Telix Pharmaceuticals Limited, while starting from a smaller base, has demonstrated impressive growth, particularly in recent years. From 2021 to 2023, Telix's revenue increased by an astounding 9,900%, reflecting its expanding market presence and innovative product offerings.

This comparison not only underscores the dynamic nature of the pharmaceutical sector but also highlights the diverse strategies companies employ to achieve financial success.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025